SYP: DEFLAZACORT ORAL SUSP.

Specific:

• Bone sparing corticosteroid.
• Less serious metabolic sequelae than prednisone.
• Less diabetogenic than prednisone.
• Suppresses the osteoblast function leading to smaller decreases in serum osteocalcin levels.
• Less negative impact in growth rate in children